Michal Karas

796 total citations
48 papers, 416 citations indexed

About

Michal Karas is a scholar working on Hematology, Accounting and Strategy and Management. According to data from OpenAlex, Michal Karas has authored 48 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 16 papers in Accounting and 10 papers in Strategy and Management. Recurrent topics in Michal Karas's work include Financial Distress and Bankruptcy Prediction (14 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Financial Reporting and Valuation Research (8 papers). Michal Karas is often cited by papers focused on Financial Distress and Bankruptcy Prediction (14 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Financial Reporting and Valuation Research (8 papers). Michal Karas collaborates with scholars based in Czechia, Germany and United Kingdom. Michal Karas's co-authors include Kateřina Steinerová, Vladimír Koza, Samuel Vokurka, L Holubec, Jiří Polívka, Václav Liška, Pavel Jindra, Petr Pokorný, Daniel Lysák and Alexandra Jungová and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Bone Marrow Transplantation.

In The Last Decade

Michal Karas

43 papers receiving 399 citations

Peers

Michal Karas
Konstantinos Liapis Greece
Sara De Masi Italy
Adriana Bruscato Bortoluzzo Brazil
Hiroshi Fujiki Japan
Michael G. Martin United States
Wolfgang Schultze Germany
Stefano Fontana Italy
Pearl Hock Neo Tan Singapore
Francesca Donofrıo Italy
Konstantinos Liapis Greece
Michal Karas
Citations per year, relative to Michal Karas Michal Karas (= 1×) peers Konstantinos Liapis

Countries citing papers authored by Michal Karas

Since Specialization
Citations

This map shows the geographic impact of Michal Karas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Karas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Karas more than expected).

Fields of papers citing papers by Michal Karas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Karas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Karas. The network helps show where Michal Karas may publish in the future.

Co-authorship network of co-authors of Michal Karas

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Karas. A scholar is included among the top collaborators of Michal Karas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Karas. Michal Karas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Žáčková, Daniela, Hana Klamová, Edgar Faber, et al.. (2024). Clinical efficacy and safety of first‐line nilotinib or imatinib therapy in patients with chronic myeloid leukemia—Nationwide real life data. Cancer Medicine. 13(17). e70158–e70158.
2.
Karas, Michal, et al.. (2023). A novel approach to estimating the debt capacity of European SMEs. Equilibrium Quarterly Journal of Economics and Economic Policy. 18(2). 551–581. 4 indexed citations
3.
Jungová, Alexandra, et al.. (2023). Allogeneic stem cell transplantation in patients with multiple myeloma-single center experience. Neoplasma. 70(2). 294–299. 2 indexed citations
4.
Karas, Michal, et al.. (2021). The role of financial constraint factors in predicting SME default. Equilibrium Quarterly Journal of Economics and Economic Policy. 16(4). 859–883. 24 indexed citations
5.
6.
Karas, Michal, et al.. (2020). Cash Flows Indicators in the Prediction of Financial Distress. Engineering Economics. 31(5). 525–535. 22 indexed citations
7.
Andersen, Niels Smedegaard, Martin Bornhäuser, Martin Gramatzki, et al.. (2019). Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning. Journal of Cancer Research and Clinical Oncology. 145(11). 2823–2834. 4 indexed citations
8.
Jungová, Alexandra, Samuel Vokurka, Kateřina Steinerová, et al.. (2018). Comparison of autologous hematopoietic cell transplantation performed in tandem and in disease relapse in multiple myeloma patients. Neoplasma. 65(6). 952–957. 3 indexed citations
9.
Karas, Michal, et al.. (2017). The stability of bankruptcy predictors in the construction and manufacturing industries at various times before bankruptcy. E+M Ekonomie a Management. 20(2). 116–133. 21 indexed citations
10.
Karas, Michal, et al.. (2017). Could the Coefficients Re-Estimation Solve the Industry or Time Specific Issues?. Brno University of Technology Digital Library (Brno University of Technology). 2.
11.
Karas, Michal, et al.. (2017). Non-Financial Factors of Performance: The Case of Mechanical Engineering Companies in the Czech Republic. Digitální knihovna Univerzity Pardubice (Univerzity Pardubice). 25(2). 3 indexed citations
12.
13.
Karas, Michal, et al.. (2015). PREDICTION CAPABILITIES OF BANKRUPTCY MODELS IN A DIFFERENT ENVIRONMENT: AN EXAMPLE OF THE ALTMAN MODEL UNDER THE CONDITIONS IN THE VISEGRAD GROUP COUNTRIES. Ekonomický časopis (Journal of Economics). 63(6). 9 indexed citations
14.
Karas, Michal, et al.. (2013). Identifikace faktorů ovlivňujících výkonnost podniku na bázi ROE v období 2003–2012. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Karas, Michal, et al.. (2013). Value Drivers of Processing Industry Enterprises in the Czech Republic in the Years 2007-2011. 7(13). 91–99. 2 indexed citations
16.
Liehr, Thomas, Nadezda Kosyakova, Radek Čmejla, et al.. (2013). A method to identify new molecular markers for assessing minimal residual disease in acute leukemia patients. Leukemia Research. 37(10). 1363–1373. 13 indexed citations
17.
Peková, Šoňa, Radek Čmejla, Michal Karas, et al.. (2011). A comprehensive study of TP53 mutations in chronic lymphocytic leukemia: Analysis of 1287 diagnostic and 1148 follow-up CLL samples. Leukemia Research. 35(7). 889–898. 14 indexed citations
18.
Vokurka, Samuel, Kateřina Steinerová, Michal Karas, & Vladimír Koza. (2009). Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2. Bone Marrow Transplantation. 44(9). 601–605. 42 indexed citations
19.
Peková, Šoňa, Robert Ivánek, Michal Dvořák, et al.. (2009). Molecular variability of FLT3/ITD mutants and their impact on the differentiation program of 32D cells: Implications for the biological properties of AML blasts. Leukemia Research. 33(10). 1409–1416. 4 indexed citations
20.
Lysák, Daniel, Vladimír Koza, Pavel Jindra, et al.. (2001). Allogeneic BMT in patients above 45 years of age: a single center experience. Bone Marrow Transplantation. 27(7). 723–726. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Konstantinos Liapis Breakdown of academic impact, for papers by Sara De Masi Breakdown of academic impact, for papers by Adriana Bruscato Bortoluzzo Breakdown of academic impact, for papers by Hiroshi Fujiki Breakdown of academic impact, for papers by Michael G. Martin Breakdown of academic impact, for papers by Wolfgang Schultze Breakdown of academic impact, for papers by Stefano Fontana Breakdown of academic impact, for papers by Pearl Hock Neo Tan Breakdown of academic impact, for papers by Francesca Donofrıo
Rankless by CCL
2026